CA1099269A - Process for the production of 9-hydroxydibenzo ¬b, d| pyrans and intermediates therefor - Google Patents

Process for the production of 9-hydroxydibenzo ¬b, d| pyrans and intermediates therefor

Info

Publication number
CA1099269A
CA1099269A CA263,717A CA263717A CA1099269A CA 1099269 A CA1099269 A CA 1099269A CA 263717 A CA263717 A CA 263717A CA 1099269 A CA1099269 A CA 1099269A
Authority
CA
Canada
Prior art keywords
formula
compound
methyl
hydrogen
alk2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA263,717A
Other languages
English (en)
French (fr)
Inventor
Jasjit S. Bindra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Priority to CA354,688A priority Critical patent/CA1110240A/en
Application granted granted Critical
Publication of CA1099269A publication Critical patent/CA1099269A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • C07C37/01—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by replacing functional groups bound to a six-membered aromatic ring by hydroxy groups, e.g. by hydrolysis
    • C07C37/055—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by replacing functional groups bound to a six-membered aromatic ring by hydroxy groups, e.g. by hydrolysis the substituted group being bound to oxygen, e.g. ether group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/205—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring the aromatic ring being a non-condensed ring
    • C07C43/2055—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring the aromatic ring being a non-condensed ring containing more than one ether bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/004—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with organometalhalides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/18—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted otherwise than in position 3 or 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/20—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 hydrogenated in the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CA263,717A 1975-11-03 1976-10-19 Process for the production of 9-hydroxydibenzo ¬b, d| pyrans and intermediates therefor Expired CA1099269A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA354,688A CA1110240A (en) 1975-11-03 1980-06-24 Dibenzo b,d, pyranones useful as intermediates in the production of pharmaceuticals

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62821075A 1975-11-03 1975-11-03
US628,210 1975-11-03

Publications (1)

Publication Number Publication Date
CA1099269A true CA1099269A (en) 1981-04-14

Family

ID=24517939

Family Applications (1)

Application Number Title Priority Date Filing Date
CA263,717A Expired CA1099269A (en) 1975-11-03 1976-10-19 Process for the production of 9-hydroxydibenzo ¬b, d| pyrans and intermediates therefor

Country Status (25)

Country Link
JP (3) JPS5277065A (cs)
AR (1) AR220521A1 (cs)
BG (3) BG27552A3 (cs)
CA (1) CA1099269A (cs)
CH (1) CH622790A5 (cs)
CS (1) CS207571B2 (cs)
DD (3) DD129214A5 (cs)
DK (1) DK495876A (cs)
EG (1) EG12648A (cs)
ES (3) ES452772A1 (cs)
FI (1) FI763131A7 (cs)
GR (1) GR65202B (cs)
HU (1) HU178321B (cs)
IE (1) IE43700B1 (cs)
IL (1) IL50717A (cs)
NO (1) NO148745C (cs)
NZ (1) NZ182368A (cs)
PH (3) PH14811A (cs)
PL (1) PL125297B1 (cs)
PT (1) PT65781B (cs)
RO (4) RO76124A (cs)
SE (1) SE432251B (cs)
SU (4) SU843748A3 (cs)
YU (1) YU268176A (cs)
ZA (1) ZA766281B (cs)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0765890A (ja) * 1993-08-26 1995-03-10 Sumitomo Wiring Syst Ltd コネクタ
JP2988237B2 (ja) * 1994-01-31 1999-12-13 住友電装株式会社 簡易防水コネクタ
JP5037799B2 (ja) * 2005-06-30 2012-10-03 パナソニック株式会社 テレビコンセント
JP7516898B2 (ja) 2020-06-16 2024-07-17 株式会社アイシン シフト装置

Also Published As

Publication number Publication date
PH14383A (en) 1981-06-24
CS207571B2 (en) 1981-08-31
FI763131A7 (cs) 1977-05-04
SE7611275L (sv) 1977-06-27
ES462784A1 (es) 1978-06-01
DD129214A5 (de) 1978-01-04
AR220521A1 (es) 1980-11-14
RO75876A (ro) 1981-05-30
JPS56103173A (en) 1981-08-18
PL125297B1 (en) 1983-04-30
DK495876A (da) 1977-05-04
IL50717A0 (en) 1976-12-31
DD137837A5 (de) 1979-09-26
BG27552A3 (bg) 1979-11-12
NO148745B (no) 1983-08-29
ES452772A1 (es) 1978-02-16
PT65781A (en) 1976-12-01
RO76124A (ro) 1981-04-30
DD143774A5 (de) 1980-09-10
SU677660A3 (ru) 1979-07-30
SU843748A3 (ru) 1981-06-30
IE43700L (en) 1977-05-03
NZ182368A (en) 1978-04-03
SU677661A3 (ru) 1979-07-30
IL50717A (en) 1981-09-13
IE43700B1 (en) 1981-05-06
JPS564555B2 (cs) 1981-01-30
JPS5943958B2 (ja) 1984-10-25
PT65781B (en) 1978-05-10
RO71411A (ro) 1982-12-06
GR65202B (en) 1980-07-29
BG28057A4 (bg) 1980-02-25
NO148745C (no) 1983-12-07
PH14811A (en) 1981-12-14
BG28058A4 (bg) 1980-02-25
YU268176A (en) 1983-10-31
HU178321B (en) 1982-04-28
JPS5589280A (en) 1980-07-05
EG12648A (en) 1979-06-30
JPS5277065A (en) 1977-06-29
CH622790A5 (en) 1981-04-30
RO76006A (ro) 1981-03-30
SE432251B (sv) 1984-03-26
ES462783A1 (es) 1978-06-01
SU784772A4 (ru) 1980-11-30
ZA766281B (en) 1977-09-28
JPS5943955B2 (ja) 1984-10-25
PH16788A (en) 1984-02-28
PL193435A1 (cs) 1980-01-28
NO763725L (cs) 1977-05-04

Similar Documents

Publication Publication Date Title
US4143139A (en) 9-Hydroxydibenzo[b,d]pyrans and intermediates
US4206225A (en) 2,10-Disubstituted dibenzo[b,d]pyrans and benzo[c]quinolines
SE430983B (sv) Farmaceutiskt aktiva derivat av 1-hydroxi-oktahydrofenantren-9-on, 1,9-dihydroxi-oktahydrofenantren och 1-hydroxi-hexa-hydrofenantren-9-on
CZ138592A3 (en) Acetic acid derivative, process of its preparation and a pharmaceutical composition in which said derivative is comprised
EP0045171B1 (en) 9-amino-1-hydroxyoctahydrobenzo(c)quinolines and derivatives thereof
AP188A (en) Novel aryloxy alcohol benzenes, processes for their preparation as well as the pharmaceutical compositions containing them.
NL8303358A (nl) Cycloalkanonen, onverzadigde analogen ervan en werkwijzen voor hun bereiding en toepassing.
US4243674A (en) 9-Hydroxydibenzo[b,d]pyrans and intermediates therefore
EP0089781B1 (en) Bicyclic benzo fused compounds
IL49285A (en) The preparation of 2-(6-alkoxy-carbonylhexyl)-2-cyclopenten-1-one
CA1095909A (en) 9-hydroxyhexahydrobenzol¬c| quinolines and intermediates therefor
KR850001337B1 (ko) 4-[2-히드록시-4-(치환)페닐]나프탈렌-2(1h)-온 및 2-올, 이들 유도체 및 이들 중간체의 제조 방법
US4270005A (en) 1,9-Dihydroxyoctahydrophenanthrenes and intermediates therefor
PL125297B1 (en) Process for preparing novel dibenzo/b,d/-pyranes
US4927819A (en) Cyclo-octane neuroprotective agents
Nicolaides et al. Reactions of o-quinones with 2, 5-dimethylthiophene-3, 4-diylbis (methylenetriphenylphosphonium chloride) in the presence of lithium hydroxide. Application of phase transfer catalysis
US3929902A (en) 1-Phenyl-2, 3-butadien-1-ols
US3420841A (en) 1,3-di-(4-pyridyl)propane derivatives
US3047571A (en) Derivatives of oxopiperidinyl phenthiazines
KR790001321B1 (ko) 디벤조 피란류의 제조방법
CA1110240A (en) Dibenzo b,d, pyranones useful as intermediates in the production of pharmaceuticals
US4310669A (en) Intermediates to 1,9-dihydroxyoctahydrophenanthrenes
US4486609A (en) Pharmacologically active 4-[2-hydroxy-4-(substituted)phenyl]naphthalen-2(1H)-ones and 2-ols, derivatives thereof and intermediates therefor
US4933475A (en) Pharmacologically active 4-[2-hydroxy-4-(substituted)phenyl]naphthalen-2(1H)-ones and 2-ols, derivatives thereof and intermediates therefor
Tanada et al. Synthesis and Absolute Configuration of (−)‐Subersic Acid, a Sponge‐Derived, Terpenoidal Inhibitor of Human 15‐Lipoxygenase

Legal Events

Date Code Title Description
MKEX Expiry